[1]
A, P.K., G, P., Sn, M., Ap, S., Swamy, V. and Rama, S. 2018. CLINICAL OUTCOMES OF USE OF HYDROXYCHLOROQUINE IN PARADOXICAL TUBERCULOSIS-IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV-INFECTED PATIENTS. Asian Journal of Pharmaceutical and Clinical Research. 11, 2 (Feb. 2018), 439–441. DOI:https://doi.org/10.22159/ajpcr.2018.v11i2.21995.